Contact Us

Bextra
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

Did you take more than 400 MG of Bextra a day?

Have any of the following side effects occurred? (Please check all that apply.)






Please further describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Bextra Lawsuit

Doctor Accused of Falsifying Drug Studies Pleads Guilty

Feb 23, 2010
| Parker Waichman LLP
Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health...

Pfizer Geodon Whistleblower Represented by Parker Waichman LLP

Sep 9, 2009
| Parker Waichman LLP
A whistleblower who was involved in last week's record breaking $2.3 billion Pfizer settlement was represented by the Great Neck, NY law firm of...

Pfizer's Illegal Promotion of Bextra and Other Drugs Results in Record Settlement, Guilty Plea

Sep 3, 2009
| Parker Waichman LLP
Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Company Inc., have agreed to pay a record-setting $2.3 billion to settle claims arising from...

Pfizer to Pay Big Fine Over Bextra Promotion

Jan 29, 2009
| Parker Waichman LLP
Drug maker Pfizer, Inc. led the news with two announcements this week:  It took a record-breaking hit of $2.3 billion over investigations into...

Arizona Bextra Lawsuit Charges Pfizer with Deceptive Marketing

Nov 19, 2008
| Parker Waichman LLP
In 2005, the U.S. Food and Drug Administration (FDA) and European regulators formally asked Pfizer, Inc. to suspend sales of Bextra in the United...

COX-2 Inhibitors More Likely to Raise Heart Risks Than Other NSAIDs

Nov 5, 2008
| Parker Waichman LLP
A new study that confirms the heart risks associated with a class of drugs called NSAIDs has found that the increased risk correlates to the specific...

Pfizer Announces Bextra, Celebrex Settlement

Oct 17, 2008
| Parker Waichman LLP
Pfizer has reached a tentative agreement to settle lawsuits involving its Bextra and Celebrex painkillers for  $894 million.  If it goes...

Study Confirms Vioxx and Bextra Dangers

Aug 8, 2008
| Parker Waichman LLP
Another study has confirmed that Vioxx and Bextra increase the risk of having a stroke.  Both Bextra and Vioxx were removed from the market...

Pfizer Negotiating Celebrex, Bextra Settlements

May 5, 2008
| Parker Waichman LLP
Celebrex and Bextra maker Pfizer Inc. has begun to settle injury claims against the painkillers.  It is estimated that between 7,000 and 9,000...

Ex Pfizer Sales Manager Indicted For Allegedly Obstructing Off-label Marketing Probe

Mar 14, 2008
| Parker Waichman LLP
An investigation of Pfizer Inc. drug marketing efforts has resulted in charges being filed against a former Pfizer sales manager.  The four...

Page 1/14 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]